Nucleolin aptamer conjugated MSNPs-PLR-PEG multifunctional nanoconstructs for targeted co-delivery of anticancer drug and siRNA to counter drug resistance in …
The emergence of drug resistance in cancer cells is among the major challenges for treating
cancer. In the last few years, the co-delivery of drug and siRNA has shown promising results …
cancer. In the last few years, the co-delivery of drug and siRNA has shown promising results …
Nucleolin aptamer conjugated MSNPs-PLR-PEG multifunctional nanoconstructs for targeted co-delivery of anticancer drug and siRNA to counter drug resistance in …
P Kumar, R Salve, KM Paknikar… - … journal of biological …, 2023 - pubmed.ncbi.nlm.nih.gov
The emergence of drug resistance in cancer cells is among the major challenges for treating
cancer. In the last few years, the co-delivery of drug and siRNA has shown promising results …
cancer. In the last few years, the co-delivery of drug and siRNA has shown promising results …
Nucleolin aptamer conjugated MSNPs-PLR-PEG multifunctional nanoconstructs for targeted co-delivery of anticancer drug and siRNA to counter drug resistance in …
P Kumar, R Salve, KM Paknikar… - International Journal of …, 2022 - europepmc.org
The emergence of drug resistance in cancer cells is among the major challenges for treating
cancer. In the last few years, the co-delivery of drug and siRNA has shown promising results …
cancer. In the last few years, the co-delivery of drug and siRNA has shown promising results …
